Dr. Herbert Wachtel is a Senior Principal Scientist at Boehringer Ingelheim, Germany. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. Within its business unit Prescription Medicines, Respiratory is one of the major areas. Herbert has joined the company in 1998 and since then he has been involved in basics of inhalation therapy, e.g. formulation development, novel methods for particle sizing, design of aerodynamic components in inhalers and aerosol therapy in children. In his spare time Herbert serves as a lecturer on the subject of Pharmaceutical Technology at the Johannes Gutenberg-University in Mainz.
Herbert has studied Physics at the University of Stuttgart where he investigated conducting molecular solid films and surfaces before switching to the field of aerosolized drug delivery. Apart from CAD tools, Herbert regularly applies Computational Fluid Dynamics (CFD) and he advances up-to-date ‘in vivo-in vitro correlations’ (IV-IVC) for the optimization of devices in the industrial setting.
